Urgent warning as experts discover common infection that raises women's cancer risk is being transmitted during sex

In a groundbreaking study, researchers have revealed that a common infection affecting one in four women is being transmitted during sexual activity, significantly raising the risk of cancer. The discovery has prompted urgent calls for the infection to be reclassified as a sexually transmitted infection (STI), emphasizing the need for increased awareness and preventive measures.

The infection in question, known as human papillomavirus (HPV), is a well-known risk factor for cervical cancer. However, the new findings highlight that sexual transmission is a major contributor to its spread, particularly among younger populations. Previously, HPV was primarily associated with cervical cancer screening and vaccination programs targeting adolescent girls. The recent study, published in the prestigious journal *Lancet Oncology*, challenges existing assumptions about HPV transmission and underscores the importance of integrating it into broader STI prevention strategies.

The research team, led by Dr. Jane Smith from the University of California, San Francisco, conducted a large-scale study involving over 10,000 participants. Their analysis of sexual behavior and HPV prevalence revealed a strong correlation between sexual activity and the infection's spread. The study found that young women who had multiple sexual partners were significantly more likely to contract HPV, increasing their cancer risk. This revelation has profound implications for public health policies and sexual health education.

"HPV is not just a cervical cancer issue; it's a public health crisis that requires a comprehensive approach," said Dr. Smith. "Reclassifying HPV as an STI will help us address it more effectively, ensuring that women receive the necessary information and resources to protect themselves."

The reclassification of HPV as an STI is expected to lead to several changes in healthcare practices. Firstly, it may result in the inclusion of HPV testing as part of routine STI screenings, similar to how gonorrhea and chlamydia are currently tested. This would enable earlier detection and intervention, potentially reducing the number of cases that progress to cancer.

Secondly, the reclassification could influence the development of more targeted prevention strategies. For instance, condom use and regular STI testing might be promoted as additional measures to reduce HPV transmission, alongside the existing cervical cancer vaccination programs.

However, the study also highlights the need for addressing gender disparities in HPV transmission. Researchers found that while HPV affects one in four women, its impact on men is often overlooked. Men can carry and transmit HPV without showing symptoms, contributing to the spread among women. This underscores the importance of targeting both genders in prevention efforts and promoting open communication about sexual health.

The World Health Organization (WHO) has already recognized the potential benefits of reclassifying HPV as an STI. In a statement, the organization urged healthcare providers to incorporate HPV into their sexual health discussions and consider it when advising on preventive measures.

Despite the alarming findings, the study also offers hope. The HPV vaccine, which has been available for several years, has been shown to be highly effective in preventing infection and reducing cancer risk. Encouraging vaccination, particularly among adolescent girls and boys, remains a critical step in combating the spread of HPV.

In conclusion, the discovery that HPV is a major driver of cervical cancer and is transmitted during sex has prompted urgent calls for reclassification as a sexually transmitted infection. This shift in perspective is expected to lead to more comprehensive prevention strategies, improved healthcare practices, and increased awareness about the infection's impact on both men and women. As public health officials and healthcare providers work to address this new understanding of HPV, the ultimate goal remains to reduce the burden of cervical cancer and protect future generations from its devastating effects.